David J. Reeves

656 total citations
38 papers, 461 citations indexed

About

David J. Reeves is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, David J. Reeves has authored 38 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in David J. Reeves's work include Neutropenia and Cancer Infections (5 papers), Chemotherapy-related skin toxicity (4 papers) and Cancer Treatment and Pharmacology (4 papers). David J. Reeves is often cited by papers focused on Neutropenia and Cancer Infections (5 papers), Chemotherapy-related skin toxicity (4 papers) and Cancer Treatment and Pharmacology (4 papers). David J. Reeves collaborates with scholars based in United States, Australia and United Kingdom. David J. Reeves's co-authors include Anthony J. Perissinotti, Ruemu Birhiray, Emily Bain, Elizabeth S. Moore, Vijay U. Rao, Meghana Raghavendra, Atul Chugh, Susan Dent, Ana Barac and Rupal O’Quinn and has published in prestigious journals such as Journal of the American College of Cardiology, Critical Care Medicine and British Journal of Clinical Pharmacology.

In The Last Decade

David J. Reeves

36 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David J. Reeves United States 14 187 171 125 95 54 38 461
Jeong Hyun Kim South Korea 19 315 1.7× 95 0.6× 86 0.7× 54 0.6× 41 0.8× 61 732
Hongtao Hu China 15 94 0.5× 66 0.4× 116 0.9× 64 0.7× 36 0.7× 63 541
Yiwei Liu China 12 155 0.8× 167 1.0× 98 0.8× 74 0.8× 84 1.6× 41 529
Aram Barbaryan United States 10 173 0.9× 92 0.5× 96 0.8× 99 1.0× 11 0.2× 30 400
Juan Antonio Virizuela Spain 12 165 0.9× 231 1.4× 78 0.6× 50 0.5× 32 0.6× 57 587
Tony Ibrahim Lebanon 11 89 0.5× 160 0.9× 40 0.3× 24 0.3× 33 0.6× 46 393
Linkun Hu China 14 129 0.7× 66 0.4× 168 1.3× 40 0.4× 18 0.3× 37 538
Mona Beaunoyer Canada 15 142 0.8× 119 0.7× 140 1.1× 42 0.4× 39 0.7× 35 718
Abdo Haddad United States 13 107 0.6× 143 0.8× 45 0.4× 27 0.3× 19 0.4× 41 434
A. Pujol France 7 84 0.4× 228 1.3× 90 0.7× 53 0.6× 37 0.7× 11 405

Countries citing papers authored by David J. Reeves

Since Specialization
Citations

This map shows the geographic impact of David J. Reeves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Reeves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Reeves more than expected).

Fields of papers citing papers by David J. Reeves

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Reeves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Reeves. The network helps show where David J. Reeves may publish in the future.

Co-authorship network of co-authors of David J. Reeves

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Reeves. A scholar is included among the top collaborators of David J. Reeves based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Reeves. David J. Reeves is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schultze, M. & David J. Reeves. (2024). Pirtobrutinib: A New and Distinctive Treatment Option for B-Cell Malignancies. Annals of Pharmacotherapy. 58(10). 1064–1073. 3 indexed citations
2.
3.
4.
Reeves, David J., et al.. (2022). Nivolumab/Relatlimab: A Novel Addition to Immune Checkpoint Inhibitor Therapy in Unresectable or Metastatic Melanoma. Annals of Pharmacotherapy. 57(6). 738–745. 14 indexed citations
5.
Reeves, David J., et al.. (2022). Targeting EGFR Exon 20 Insertion Mutation in Non–small cell Lung Cancer: Amivantamab and Mobocertinib. Annals of Pharmacotherapy. 57(2). 198–206. 14 indexed citations
6.
Reeves, David J., et al.. (2022). Outcomes and Management of Immune Checkpoint Inhibitor–Induced Hypothyroidism: A Retrospective Analysis. Annals of Pharmacotherapy. 56(10). 1100–1105. 2 indexed citations
7.
Reeves, David J., et al.. (2021). Vascular endothelial growth factor inhibitor induced hypertension: Retrospective analysis of the impact of blood pressure elevations on outcomes. Journal of Oncology Pharmacy Practice. 28(2). 265–273. 5 indexed citations
8.
Reeves, David J., et al.. (2021). Embolia Cutis Medicamentosa (Nicolau Syndrome) Secondary to Intramuscular Fulvestrant Injection: A Case Report. Journal of Pharmacy Practice. 35(6). 1034–1038. 3 indexed citations
9.
Rao, Vijay U., David J. Reeves, Atul Chugh, et al.. (2021). Clinical Approach to Cardiovascular Toxicity of Oral Antineoplastic Agents. Journal of the American College of Cardiology. 77(21). 2693–2716. 41 indexed citations
10.
Reeves, David J., et al.. (2020). Tolerability of Highly Protein Bound Targeted Oral Oncolytic Drugs in Patients With Hypoalbuminemia: A Retrospective Analysis. Annals of Pharmacotherapy. 55(2). 165–173. 5 indexed citations
11.
Reeves, David J., et al.. (2020). Lurbinectedin: A New Treatment Option for Relapsed/Refractory Small-Cell Lung Cancer. Annals of Pharmacotherapy. 55(9). 1172–1179. 9 indexed citations
12.
Reeves, David J., et al.. (2019). Chemotherapy-induced oral mucositis management: A retrospective analysis of MuGard, Caphosol, and standard supportive care measures. Journal of Oncology Pharmacy Practice. 26(3). 521–528. 10 indexed citations
13.
Reeves, David J., et al.. (2019). Use of Pamidronate for Hypercalcemia of Malignancy in Renal Dysfunction. Journal of Pharmacy Practice. 34(4). 553–557. 5 indexed citations
14.
Reeves, David J., et al.. (2019). Trastuzumab/Hyaluronidase-oysk: A New Option for Patients With HER2-Positive Breast Cancer. Annals of Pharmacotherapy. 54(3). 254–261. 11 indexed citations
15.
Birhiray, Ruemu, et al.. (2017). Severe Hypoglycemia Caused by Lenalidomide. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 38(1). e1–e6.
16.
Reeves, David J., et al.. (2017). Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy. Supportive Care in Cancer. 25(12). 3715–3721. 4 indexed citations
17.
Reeves, David J., et al.. (2016). Methotrexate Elimination When Coadministered With Levetiracetam. Annals of Pharmacotherapy. 50(12). 1016–1022. 17 indexed citations
18.
Reeves, David J., et al.. (2014). Tolerability of induction chemotherapy dosing practices in acute myeloid leukemia patients. Leukemia Research. 39(2). 173–176. 9 indexed citations
19.
Reeves, David J., et al.. (2012). Leukopenia associated with long-term colchicine administration. American Journal of Health-System Pharmacy. 69(24). 2147–2148. 4 indexed citations
20.
Reeves, David J., et al.. (2009). Treatment of metastatic renal cell carcinoma. Cancer Chemotherapy and Pharmacology. 64(1). 11–25. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeong Hyun Kim Breakdown of academic impact, for papers by Hongtao Hu Breakdown of academic impact, for papers by Yiwei Liu Breakdown of academic impact, for papers by Aram Barbaryan Breakdown of academic impact, for papers by Juan Antonio Virizuela Breakdown of academic impact, for papers by Tony Ibrahim Breakdown of academic impact, for papers by Linkun Hu Breakdown of academic impact, for papers by Mona Beaunoyer Breakdown of academic impact, for papers by Abdo Haddad Breakdown of academic impact, for papers by A. Pujol
Rankless by CCL
2026